Hannover Re (HNR1) Given a €118.00 Price Target at HSBC

HSBC set a €118.00 ($137.21) price objective on Hannover Re (FRA:HNR1) in a report published on Monday, Borsen Zeitung reports. The firm currently has a sell rating on the stock.

HNR1 has been the subject of several other reports. Goldman Sachs Group set a €120.00 ($139.53) price target on Hannover Re and gave the company a neutral rating in a report on Tuesday, April 23rd. Barclays set a €111.70 ($129.88) price objective on Hannover Re and gave the company a sell rating in a research note on Wednesday, April 3rd. DZ Bank reissued a neutral rating on shares of Hannover Re in a research note on Friday, March 8th. Deutsche Bank set a €116.00 ($134.88) price objective on Hannover Re and gave the company a neutral rating in a research note on Friday, April 12th. Finally, JPMorgan Chase & Co. set a €114.00 ($132.56) price objective on Hannover Re and gave the company a neutral rating in a research note on Monday, February 11th. Five equities research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company’s stock. The stock presently has an average rating of Hold and an average price target of €118.93 ($138.29).

Shares of Hannover Re stock opened at €137.70 ($160.12) on Monday. Hannover Re has a 52-week low of €94.75 ($110.17) and a 52-week high of €116.37 ($135.31).

Hannover Re Company Profile

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

See Also: Penny Stocks

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.